<DOC>
	<DOCNO>NCT00433992</DOCNO>
	<brief_summary>The purpose study observe effect certain anti-HIV medication mitochondrial activity fat cell death . This study enroll participant another study , ACTG A5202 , treatment regimen include zidovudine , stavudine , thymidine-containing anti-HIV medication .</brief_summary>
	<brief_title>Metabolic Effects Non-Thymidine Analogue Anti-HIV Medications</brief_title>
	<detailed_description>The main objective study observe effect anti-HIV medication lack thymidine mitochondrial metabolism adipocyte apoptosis ( fat cell death ) . Changes mitochondrial metabolism increase adipocyte apoptosis associate lipoatrophy . Lipoatrophy common condition characterize loss subcutaneous fat cause many anti-HIV medication . This study examine metabolic consequence use thymidine analogue-sparing treatment regimen . This study evaluate HIV infected patient enrol ACTG A5202 , start first nucleoside reverse transcriptase inhibitor ( NRTI ) -containing regimen . This regimen include either tenofovir disoproxil fumarate/emtricitabine ( TDF/FTC ) abacavir/lamivudine ( ABC/3TC ) , thymidine-sparing regimen . The change mitochondrial activity fat cell death compare participant take thymidine-sparing regimen ( TDF/FTC ABC/3TC ) thymidine-containing regimen . This study last 96 week , two study visit occur entry another visit Week 96 . During visit , dual energy x-ray absorptiometry ( DEXA ) scan blood collection occur , fat biopsy perform low abdomen local anesthetic .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<criteria>HIVinfected Enrolling ACTG A5202 metabolic substudy ACTG A5224 Bleeding problem Can undergo fat biopsy Require aspirin anytime 7day period prior biopsy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Mitochondria</keyword>
	<keyword>Fat apoptosis</keyword>
	<keyword>Lipoatrophy</keyword>
	<keyword>Lipodystrophy</keyword>
	<keyword>Thymidine</keyword>
	<keyword>Treatment experience</keyword>
</DOC>